Neostigmine .5 mg/mL
Neostigmine · INJECTION · Dr.Reddy's Laboratories Inc
Neostigmine is an injectable medication given intravenously that works by increasing the levels of a neurotransmitter called acetylcholine in your body. It is used to treat conditions such as myasthenia gravis, reverse certain types of anesthesia, and improve muscle strength in specific neuromuscular disorders.
Key Facts
- Brand Name
- Neostigmine
- Generic Name
- Neostigmine
- NDC Code (Product)
43598-528- Manufacturer
- Dr.Reddy's Laboratories Inc
- Strength
- .5 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA209135
- Marketing Start
- 09/04/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Neostigmine used for?
Neostigmine is an injectable medication given intravenously that works by increasing the levels of a neurotransmitter called acetylcholine in your body. It is used to treat conditions such as myasthenia gravis, reverse certain types of anesthesia, and improve muscle strength in specific neuromuscular disorders.
Is Neostigmine a controlled substance?
Neostigmine is not classified as a controlled substance by the DEA.
What is the generic name for Neostigmine?
The generic name for Neostigmine is Neostigmine. There are 12 other brand versions of Neostigmine.
What is the NDC code for Neostigmine .5 mg/mL?
The NDC (National Drug Code) for Neostigmine .5 mg/mL is 43598-528, listed by Dr.Reddy's Laboratories Inc.
Other Neostigmine Brands
See all →- Neostigmine Methylsulfate1 mg/mL72572-462
- Neostigmine Methylsulfate1 mg/mL0641-6265
- NEOSTIGMINE METHYLSULFATE1 mg/mL55150-349
- NEOSTIGMINE METHYLSULFATE1 mg/mL71872-7143
- Neostigmine Methylsulfate1 mg/mL71872-7271
- NEOSTIGMINE METHYLSULFATE1 mg/mL71872-7322
- NEOSTIGMINE METHYLSULFATE.5 mg/mL0548-9601
- Neostigmine Methylsulfate1 mg/mL0641-6149
- Neostigmine Methylsulfate.5 mg/mL0641-6264
- Neostigmine methylsulfate1 mg/mL84549-172
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)